Tivicay 50 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FTWN1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,003
Award facts
- Contract value 100% obligated
- $4,002.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $4,002.96 to DMS Pharmaceutical Group Inc. for TIVICAY 50 mg tablets (30-count packaging) on September 24, 2025, with completion scheduled for September 25, 2025. This firm fixed-price delivery order represents a single procurement action under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $499,999,999 through November 2026. The contract carries no set-aside designation, allowing the vendor to compete on an unrestricted basis despite its status as a woman-owned small business. Performance of this order will be executed at the contractor's facility in Conshohocken, Pennsylvania.
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, serves as a critical supplier within the federal pharmaceutical supply chain. The company leverages its position under the DLA's SPE2DB program to provide comprehensive pharmaceutical distribution to military health facilities, encompassing branded and generic prescription drugs, biologics, and medical consumables. This particular delivery order for TIVICAY—an antiretroviral medication used in HIV treatment—exemplifies the vendor's role in supporting the Department of Defense healthcare infrastructure with specialized pharmaceutical products essential to military medical operations.
Quick answers
Who was awarded contract SPE2DB25FTWN1?
SPE2DB25FTWN1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 24, 2025.
How much is contract SPE2DB25FTWN1 worth?
The government has obligated $4,003 on SPE2DB25FTWN1.
Is contract SPE2DB25FTWN1 an order under another contract?
Yes. SPE2DB25FTWN1 is a delivery order under SPE2DB20D6037, an indefinite delivery contract.
Was contract SPE2DB25FTWN1 competed?
The extent of competition for SPE2DB25FTWN1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award